Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. - Aschner,P.; Kipnes,MS.; Lunceford,JK.; Sanchez,M.; Mickel,C. (Diabetes Care, 2006)